Cargando…
Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor
BACKGROUND: Apelin signalling pathways have important cardiovascular and metabolic functions. Recently, apelin-36-[L28A] and apelin-36-[L28C(30kDa-PEG)], were reported to function independent of the apelin receptor in vivo to produce beneficial metabolic effects without modulating blood pressure. We...
Autores principales: | Nyimanu, Duuamene, Kuc, Rhoda E., Williams, Thomas L., Bednarek, Maria, Ambery, Philip, Jermutus, Lutz, Maguire, Janet J., Davenport, Anthony P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838674/ https://www.ncbi.nlm.nih.gov/pubmed/31472173 http://dx.doi.org/10.1016/j.peptides.2019.170139 |
Ejemplares similares
-
Development and validation of an LC-MS/MS method for detection and quantification of in vivo derived metabolites of [Pyr(1)]apelin-13 in humans
por: Nyimanu, Duuamene, et al.
Publicado: (2019) -
The therapeutic potential of apelin in kidney disease
por: Chapman, Fiona A., et al.
Publicado: (2021) -
Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney function
por: Nyimanu, Duuamene, et al.
Publicado: (2022) -
Plasma levels of apelin are reduced in patients with liver fibrosis and cirrhosis but are not correlated with circulating levels of bone morphogenetic protein 9 and 10
por: Owen, Nicola E., et al.
Publicado: (2021) -
The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo
por: Read, Cai, et al.
Publicado: (2021)